7A7 Stock Chart & Stats
€0.10
€0.00(0.00%)
At close: 4:00 PM EST
€0.10
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.10 - €0.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.49M
Enterprise Value€23.31M
Total Cash (Recent Filing)€214.33K
Total Debt (Recent Filing)€17.31M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding110,934,220
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-0.99
Price to Sales (P/S)0.33
P/FCF Ratio-2.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Profitability ImprovementTurning EBIT positive demonstrates the business can reach operating profitability and absorb some fixed costs, a durable improvement versus prior years. Solid gross profit implies underlying unit economics remain viable, providing a foundation for sustainable margins if revenue stabilizes.
Narrowing Free Cash Flow LossesMaterial reduction in free cash flow losses signals improving cash conversion and operational efficiency. If the trend continues, it lessens reliance on external financing and supports reinvestment capacity, a structural improvement in the company’s cash-generation profile.
Clear Progress On Operating PerformanceDocumented progress in operating metrics indicates management has begun to fix core business drivers. Sustained execution on these improvements could create a durable platform for recovery, allowing the company to leverage improved margins when demand stabilizes.
Bears Say
Contracting Revenue TrendA multi-year revenue contraction reduces scale benefits and weakens competitive position. Ongoing top-line decline pressures margins, makes fixed-cost absorption harder, and undermines the sustainability of recent operating gains absent a durable reversal in demand.
Stressed Balance Sheet With Negative EquityNegative shareholders' equity and high leverage materially constrain financial flexibility, increase refinancing risk, and can restrict strategic options. This structural capital weakness elevates the probability of dilution or costly capital raises to sustain operations.
Persistent Net Losses And Negative Cash FlowContinued net losses and negative operating cash flow indicate the core business remains unprofitable at the bottom line, forcing reliance on external funding. This persistent deficit constrains reinvestment, increases financing risk, and limits resilience to industry shocks.
General Cannabis News
7A7 FAQ
What was General Cannabis Corp’s price range in the past 12 months?
General Cannabis Corp lowest stock price was €0.10 and its highest was €0.10 in the past 12 months.
What is General Cannabis Corp’s market cap?
General Cannabis Corp’s market cap is €1.49M.
When is General Cannabis Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were General Cannabis Corp’s earnings last quarter?
Currently, no data Available
Is General Cannabis Corp overvalued?
According to Wall Street analysts General Cannabis Corp’s price is currently Overvalued.
Does General Cannabis Corp pay dividends?
General Cannabis Corp does not currently pay dividends.
What is General Cannabis Corp’s EPS estimate?
General Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does General Cannabis Corp have?
General Cannabis Corp has 110,934,220 shares outstanding.
What happened to General Cannabis Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of General Cannabis Corp?
Currently, no hedge funds are holding shares in DE:7A7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
General Cannabis Corp
Denver, Colorado-based Trees Corporation, founded in 2013, specializes in delivering products and services to both the regulated cannabis sector and general consumers throughout the United States. Its business activities are organized into distinct retail and cultivation divisions. The company's facilities include a 17,000 square foot light-deprivation greenhouse for cultivation, a cannabis dispensary located in Englewood, Colorado, and two additional retail outlets in Portland, Oregon. Formerly known as General Cannabis Corp., the company rebranded to Trees Corporation in June 2022.
Technical Analysis
cbdMD
―
Aquestive Therapeutics
―
IM Cannabis Corp
―
―
Incannex Healthcare Limited Sponsored ADR
―